Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014, Article ID 832592, 4 pages
Case Report

Fingertips Ischemia, Nephroangiosclerosis, and Focal Segmental Glomerulosclerosis: Is Genetic Thrombophilia the Unique Explanation?

Department of Clinical & Experimental Medicine, School of Nephrology, University of Pisa, Via Paradisa 2, 56100 Pisa, Italy

Received 7 January 2014; Revised 15 February 2014; Accepted 16 February 2014; Published 17 March 2014

Academic Editor: Piotr K. Janicki

Copyright © 2014 Lisa Giovannini and Carlo Donadio. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Hussein, “High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T,” Journal of Thrombosis and Thrombolysis, vol. 34, pp. 383–387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Bhaijee, B. Jordan, D. J. Pepper, R. Leacock, and W. A. Rock Jr., “Venous thrombosis with both heterozygous factor V Leiden, (R507Q) and factor II, (G20210A) mutations,” Clinical Laboratory Science, vol. 25, pp. 199–205, 2012. View at Google Scholar
  3. Y. Saemundsson, S. V. Sveinsdottir, H. Svantesson, and P. J. Svensson, “Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation,” Journal of Thrombosis and Thrombolysis, vol. 36, pp. 324–331, 2013. View at Google Scholar
  4. F. Burzotta, K. Paciaroni, V. De Stefano et al., “Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease,” European Heart Journal, vol. 23, no. 1, pp. 26–30, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Kim and R. C. Becker, “Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies,” American Heart Journal, vol. 146, no. 6, pp. 948–957, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Koupepidou, C. Deltas, T. C. Christofides, Y. Athanasiou, I. Zouvani, and A. Pierides, “The MTHFR 677TT and 677CT/1298AC genotypes in Cypriot patients may be predisposing to hypertensive nephrosclerosis and chronic renal failure,” International Angiology, vol. 24, no. 3, pp. 287–294, 2005. View at Google Scholar · View at Scopus
  7. N. L. Kozlovskaia, L. A. Bobrova, V. V. Shkarupo, V. A. Varshavskiǐ, and N. G. Miroshnichenko, “Clinicomorphological characteristics of renal disorders in patients with genetic thrombophilia,” Terapevticheskiǐ Arkhiv, vol. 81, no. 8, pp. 30–36, 2009. View at Google Scholar · View at Scopus
  8. M. C. Amigo, “Kidney disesase in antiphospholipid syndrome,” Rheumatic Disease Clinics of North America, vol. 32, pp. 509–522, 2006. View at Google Scholar
  9. J. A. Velosa, K. Holley, V. E. Torres, and K. P. Offord, “Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis,” Mayo Clinic Proceedings, vol. 58, no. 9, pp. 568–577, 1983. View at Google Scholar · View at Scopus
  10. R. L. Goforth, H. Rennke, and S. Sethi, “Renal vascular sclerosis is associated with inherited thrombophilias,” Kidney International, vol. 70, no. 4, pp. 743–750, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Bochud, M. Burnier, and I. Guessous, “Top three pharmacogenomics and personalized medicine applications at the nexus of renal pathophysiology and cardiovascular medicine,” Current Pharmacogenomics and Personalized Medicine, vol. 9, no. 4, pp. 299–322, 2011. View at Google Scholar · View at Scopus